We are live on ! Find out more
ALNY icon

Alnylam Pharmaceuticals
ALNY

139 hedge funds and large institutions have $1.5B invested in Alnylam Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 139 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

112% more call options, than puts

Call options by funds: $15.9M | Put options by funds: $7.51M

76.71% more ownership

Funds ownership: 0% → 76.71% (+77%)

Holders
139
Holders Change
+139
Holders Change %
–
% of All Funds
4.52%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
139
Increased
–
Reduced
–
Closed
–
Calls
$15.9M
Puts
$7.51M
Net Calls
+$8.38M
Net Calls Change
+$8.38M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

ALNY Hedge Fund Activity: Q2 2013 in Review

139 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Alnylam Pharmaceuticals (ALNY) for Q2 2013, worth a combined $1.5B.

Buyers outnumbered sellers: 139 funds opened new ALNY positions and 0 closed out — a net gain of 139 holders — while 0 added to existing stakes and 0 trimmed.

  • 139 institutional investors held Alnylam Pharmaceuticals (ALNY) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.5B of Alnylam Pharmaceuticals stock for Q2 2013.
  • 139 funds opened new Alnylam Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +139 holders.

Based on aggregated 13F filings for Q2 2013.